News | December 17, 2006

FDA Says Yes to Stroke Device Study

The FDA has given CoAxia Inc. approval to move forward on a safety and feasibility study for the NeuroFlo perfusion augmentation therapy in ischemic stroke patients who present for treatment as late as 24 hours after stroke onset. Perhaps the first interventional device trial approved for this patient population, the study will enroll up to 25 patients and the results will determine future expansion to a pivotal study in late presenting stroke patients.

"This study represents another important step in applying medical devices to the treatment of acute stroke,” said Souvik Sen, M.D., director of the Stroke Service at the University of North Carolina and a co-author of the study. “There are no treatments currently approved to treat stroke patients in this eight- to 24-hour time window after symptom onset. If NeuroFlo can safely treat the large number of patients who present in this time window, it will have a major impact in stroke treatment."

The SafeFlo24 trial will evaluate the safety of the NeuroFlo perfusion augmentation catheter in stroke patients presenting for treatment between eight and 24 hours after last known to be normal. The study’s other co-authors are Lee Schwamm, M.D. from Massachusetts General Hospital, Maxim Hammer, M.D. from University of Pittsburgh Medical Center and David Liebeskind, M.D. from UCLA Medical Center. In addition to these four centers, the University of Rochester, New York, the University of Alberta, Edmonton and the University of Calgary, Calgary, will participate in the study. CoAxia expects patient enrollment to begin in the first quarter of 2007.

For more information visit www.coaxia.com

Related Content

iSchemaView RAPID Technology Now Installed in More Than 500 Stroke Centers
News | Stroke | August 28, 2018
iSchemaView announced that more than 575 stroke centers in 22 countries have selected the RAPID advanced imaging...
Breastfeeding May Help Protect Mothers Against Stroke
News | Stroke | August 22, 2018
Breastfeeding is not only good for babies, according to new research in the Journal of the American Heart Association....
iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
July 13, 2018 – iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAP
NewYork-Presbyterian Expands Mobile Stroke Treatment Unit Fleet
News | Stroke | June 11, 2018
NewYork-Presbyterian, in collaboration with Weill Cornell Medicine, Columbia University Irving Medical Center and the...
International Study Suggests Combination Therapy May Prevent Stroke in Certain People
News | Stroke | June 07, 2018
June 7, 2018 — Results from an international clinical trial show that combining...
The Vivistim device is similar to a pacemaker, which uses leads to electrically stimulate the brain. A new clinical trial at The Ohio State University Wexner Medical Center is examining use of this device for stroke rehabilitation.

A new clinical trial at The Ohio State University Wexner Medical Center is examining an implanted device that uses vagus nerve stimulation to help stroke patients regain motor function. The Vivistim device is similar to a pacemaker, which uses leads to electrically stimulate the brain. 

News | Stroke | May 09, 2018
May 9, 2018 — Stroke rehabilitation specialists at the The Ohio State University Wexner Medical Center are among the
Videos | Stroke | May 09, 2018
A new clinical trial at The Ohio State University Wexner Medical Center is examining an implanted device that uses va
Northwestern Medicine Mobile Stroke Unit Delivers Life-Saving Care 30 Minutes Sooner
News | Stroke | May 07, 2018
A new data analysis of the Northwestern Medicine Mobile Stroke Unit (MSU) found the specialized ambulance provided life...
360 Photos | Stroke | May 01, 2018
This is a 360 degree view inside the back of the Northwestern Medicine Central DuPage Hospital Mobile Stroke Unit amb
Videos | Stroke | April 30, 2018
ITN Associate Editor Jeff Zagoudis explores how the mobile stroke unit (MSU) program at Northwestern Medicine Central
Overlay Init